In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Biofarm has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
BVB:BIO - Analysts future estimates and past financials data (RON Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2025
319
101
66
81
N/A
9/30/2025
319
88
90
104
N/A
6/30/2025
309
81
76
91
N/A
3/31/2025
310
86
63
79
N/A
12/31/2024
287
74
34
58
N/A
9/30/2024
282
80
24
62
N/A
6/30/2024
259
69
35
73
N/A
3/31/2024
256
66
7
44
N/A
12/31/2023
280
77
50
80
N/A
9/30/2023
297
75
25
49
N/A
6/30/2023
301
77
29
53
N/A
3/31/2023
297
76
26
50
N/A
12/31/2022
277
71
-1
29
N/A
9/30/2022
269
71
12
41
N/A
6/30/2022
260
68
-16
9
N/A
3/31/2022
253
65
41
68
N/A
12/31/2021
239
60
48
69
N/A
9/30/2021
241
64
54
79
N/A
6/30/2021
231
61
65
93
N/A
3/31/2021
215
58
15
44
N/A
12/31/2020
216
54
12
40
N/A
9/30/2020
214
56
11
44
N/A
6/30/2020
205
52
32
52
N/A
3/31/2020
211
53
N/A
N/A
N/A
12/31/2019
195
51
53
73
N/A
9/30/2019
189
42
N/A
N/A
N/A
6/30/2019
195
44
N/A
68
N/A
3/31/2019
189
43
N/A
N/A
N/A
12/31/2018
184
38
N/A
46
N/A
9/30/2018
179
43
N/A
N/A
N/A
6/30/2018
171
38
N/A
49
N/A
3/31/2018
176
39
N/A
N/A
N/A
12/31/2017
170
36
N/A
37
N/A
9/30/2017
167
35
N/A
N/A
N/A
6/30/2017
165
35
N/A
32
N/A
3/31/2017
155
32
N/A
N/A
N/A
12/31/2016
152
29
N/A
40
N/A
9/30/2016
149
29
N/A
N/A
N/A
6/30/2016
148
27
N/A
24
N/A
3/31/2016
138
20
N/A
N/A
N/A
12/31/2015
149
27
N/A
24
N/A
9/30/2015
147
27
N/A
N/A
N/A
6/30/2015
138
27
N/A
N/A
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BIO's forecast earnings growth is above the savings rate (6.8%).
Earnings vs Market: Insufficient data to determine if BIO's earnings are forecast to grow faster than the RO market
High Growth Earnings: Insufficient data to determine if BIO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BIO's revenue is forecast to grow faster than the RO market.
High Growth Revenue: Insufficient data to determine if BIO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIO's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/07 01:04
End of Day Share Price
2026/05/07 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biofarm S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.